- Home
- IMMP vs GAU Comparison
IMMP vs GAU Comparison
Compare IMMP & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- GAU
- Stock Information
- Founded
- IMMP 1987
- GAU 1999
- Country
- IMMP Australia
- GAU Canada
- Employees
- IMMP N/A
- GAU N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- GAU
- Sector
- IMMP Health Care
- GAU
- Exchange
- IMMP Nasdaq
- GAU Nasdaq
- Market Cap
- IMMP 211.1M
- GAU 342.0M
- IPO Year
- IMMP N/A
- GAU N/A
- Fundamental
- Price
- IMMP $1.86
- GAU $1.50
- Analyst Decision
- IMMP Buy
- GAU Strong Buy
- Analyst Count
- IMMP 2
- GAU 1
- Target Price
- IMMP $8.50
- GAU $2.80
- AVG Volume (30 Days)
- IMMP 648.0K
- GAU 1.1M
- Earning Date
- IMMP 05-16-2025
- GAU 05-14-2025
- Dividend Yield
- IMMP N/A
- GAU N/A
- EPS Growth
- IMMP N/A
- GAU N/A
- EPS
- IMMP N/A
- GAU 0.02
- Revenue
- IMMP $3,019,249.00
- GAU $231,339,000.00
- Revenue This Year
- IMMP $11.25
- GAU $60.61
- Revenue Next Year
- IMMP $10.22
- GAU $36.46
- P/E Ratio
- IMMP N/A
- GAU $74.00
- Revenue Growth
- IMMP 24.11
- GAU N/A
- 52 Week Low
- IMMP $1.32
- GAU $1.00
- 52 Week High
- IMMP $3.34
- GAU $2.00
- Technical
- Relative Strength Index (RSI)
- IMMP 53.43
- GAU 58.73
- Support Level
- IMMP $1.44
- GAU $1.29
- Resistance Level
- IMMP $2.71
- GAU $1.66
- Average True Range (ATR)
- IMMP 0.17
- GAU 0.08
- MACD
- IMMP 0.05
- GAU 0.02
- Stochastic Oscillator
- IMMP 29.75
- GAU 58.75
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About GAU Galiano Gold Inc.
Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages: Nkran, Esaase, Abore and Miradani North, multiple satellite deposits and exploration projects located on the Asankrangwa Gold Belt in the Amansie West District of the Republic of Ghana (Ghana), West Africa.